Pruvost, L.; Gerlei, M.; Paris, C.; Velot, É.; Kahn, C.J.-F.; Bianchi, A.; Linder, M.
Chondroitin Sulfate Nanovectorized by LC-PUFAs Nanocarriers Extracted from Salmon (Salmo salar) by Green Process with Decreased Inflammatory Marker Expression in Interleukin-1β-Stimulated Primary Human Chondrocytes In Vitro Culture. Mar. Drugs 2024, 22, 571.
https://doi.org/10.3390/md22120571
AMA Style
Pruvost L, Gerlei M, Paris C, Velot É, Kahn CJ-F, Bianchi A, Linder M.
Chondroitin Sulfate Nanovectorized by LC-PUFAs Nanocarriers Extracted from Salmon (Salmo salar) by Green Process with Decreased Inflammatory Marker Expression in Interleukin-1β-Stimulated Primary Human Chondrocytes In Vitro Culture. Marine Drugs. 2024; 22(12):571.
https://doi.org/10.3390/md22120571
Chicago/Turabian Style
Pruvost, Louis, Maureen Gerlei, Cédric Paris, Émilie Velot, Cyril J.-F. Kahn, Arnaud Bianchi, and Michel Linder.
2024. "Chondroitin Sulfate Nanovectorized by LC-PUFAs Nanocarriers Extracted from Salmon (Salmo salar) by Green Process with Decreased Inflammatory Marker Expression in Interleukin-1β-Stimulated Primary Human Chondrocytes In Vitro Culture" Marine Drugs 22, no. 12: 571.
https://doi.org/10.3390/md22120571
APA Style
Pruvost, L., Gerlei, M., Paris, C., Velot, É., Kahn, C. J.-F., Bianchi, A., & Linder, M.
(2024). Chondroitin Sulfate Nanovectorized by LC-PUFAs Nanocarriers Extracted from Salmon (Salmo salar) by Green Process with Decreased Inflammatory Marker Expression in Interleukin-1β-Stimulated Primary Human Chondrocytes In Vitro Culture. Marine Drugs, 22(12), 571.
https://doi.org/10.3390/md22120571
